Eli Lilly Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
03 Sep 24 | SellCHF 19,802,602 | Lilly Endowment, Inc, Endowment Arm | Company | 24,084 | CHF 824.34 | |
27 Aug 24 | SellCHF 20,055,274 | Lilly Endowment, Inc, Endowment Arm | Company | 24,552 | CHF 820.03 | |
22 Aug 24 | SellCHF 2,631,456 | Lilly Endowment, Inc, Endowment Arm | Company | 3,196 | CHF 823.94 | |
10 Jul 24 | SellCHF 177,491,052 | Lilly Endowment, Inc, Endowment Arm | Company | 210,000 | CHF 849.77 | |
08 Jul 24 | SellCHF 77,130,822 | Lilly Endowment, Inc, Endowment Arm | Company | 93,593 | CHF 832.74 | |
05 Jul 24 | SellCHF 43,011,781 | Lilly Endowment, Inc, Endowment Arm | Company | 52,369 | CHF 822.28 | |
03 Jul 24 | SellCHF 7,294,782 | Lilly Endowment, Inc, Endowment Arm | Company | 8,848 | CHF 826.63 | |
01 Jul 24 | SellCHF 48,607,169 | Lilly Endowment, Inc, Endowment Arm | Company | 58,749 | CHF 828.30 | |
28 Jun 24 | SellCHF 1,184,845 | Lilly Endowment, Inc, Endowment Arm | Company | 1,441 | CHF 822.24 | |
25 Jun 24 | SellCHF 152,042,683 | Lilly Endowment, Inc, Endowment Arm | Company | 188,100 | CHF 812.99 | |
24 Jun 24 | SellCHF 13,891,616 | Lilly Endowment, Inc, Endowment Arm | Company | 17,229 | CHF 807.22 | |
20 Jun 24 | SellCHF 7,775,660 | Lilly Endowment, Inc, Endowment Arm | Company | 9,671 | CHF 805.42 | |
17 Jun 24 | SellCHF 154,033,557 | Lilly Endowment, Inc, Endowment Arm | Company | 194,978 | CHF 795.56 | |
14 Jun 24 | SellCHF 11,814,714 | Lilly Endowment, Inc, Endowment Arm | Company | 15,022 | CHF 787.30 | |
10 Jun 24 | SellCHF 58,325,954 | Lilly Endowment, Inc, Endowment Arm | Company | 75,510 | CHF 780.82 | |
07 Jun 24 | SellCHF 106,547,348 | Lilly Endowment, Inc, Endowment Arm | Company | 139,490 | CHF 767.50 | |
06 Jun 24 | SellCHF 134,240,927 | Lilly Endowment, Inc, Endowment Arm | Company | 179,617 | CHF 754.97 | |
05 Jun 24 | SellCHF 15,245,521 | Lilly Endowment, Inc, Endowment Arm | Company | 20,383 | CHF 749.15 | |
03 Jun 24 | SellCHF 143,309,553 | Lilly Endowment, Inc, Endowment Arm | Company | 192,794 | CHF 750.70 | |
31 May 24 | SellCHF 16,494,727 | Lilly Endowment, Inc, Endowment Arm | Company | 22,206 | CHF 743.80 | |
29 May 24 | SellCHF 96,542,614 | Lilly Endowment, Inc, Endowment Arm | Company | 130,385 | CHF 744.37 | |
28 May 24 | SellCHF 1,512,173 | Lilly Endowment, Inc, Endowment Arm | Company | 2,052 | CHF 736.93 | |
24 May 24 | SellCHF 68,460,591 | Lilly Endowment, Inc, Endowment Arm | Company | 92,563 | CHF 739.61 | |
23 May 24 | SellCHF 37,602,653 | Lilly Endowment, Inc, Endowment Arm | Company | 50,767 | CHF 750.30 | |
22 May 24 | SellCHF 9,534,952 | Lilly Endowment, Inc, Endowment Arm | Company | 12,974 | CHF 734.93 | |
21 May 24 | SellCHF 136,612,755 | Lilly Endowment, Inc, Endowment Arm | Company | 186,259 | CHF 740.31 | |
16 Feb 24 | SellCHF 116,680,259 | Lilly Endowment, Inc, Endowment Arm | Company | 169,684 | CHF 698.27 | |
15 Feb 24 | SellCHF 33,721,167 | Lilly Endowment, Inc, Endowment Arm | Company | 50,316 | CHF 671.77 | |
09 Feb 24 | SellCHF 133,619,533 | Lilly Endowment, Inc, Endowment Arm | Company | 206,257 | CHF 651.89 | |
08 Feb 24 | SellCHF 5,658,050 | Lilly Endowment, Inc, Endowment Arm | Company | 8,743 | CHF 647.15 | |
31 Jan 24 | SellCHF 43,783,847 | Lilly Endowment, Inc, Endowment Arm | Company | 78,573 | CHF 569.91 | |
30 Jan 24 | SellCHF 42,450,000 | Lilly Endowment, Inc, Endowment Arm | Company | 76,215 | CHF 557.89 | |
29 Jan 24 | SellCHF 30,110,735 | Lilly Endowment, Inc, Endowment Arm | Company | 54,032 | CHF 557.28 | |
16 Jan 24 | SellCHF 655,054 | Lilly Endowment, Inc, Endowment Arm | Company | 1,180 | CHF 555.62 | |
11 Jan 24 | SellCHF 6,695,959 | Lilly Endowment, Inc, Endowment Arm | Company | 12,344 | CHF 546.72 | |
10 Jan 24 | SellCHF 87,937,001 | Lilly Endowment, Inc, Endowment Arm | Company | 163,730 | CHF 541.94 | |
09 Jan 24 | SellCHF 18,591,189 | Lilly Endowment, Inc, Endowment Arm | Company | 34,538 | CHF 539.65 | |
04 Jan 24 | SellCHF 7,707,816 | Lilly Endowment, Inc, Endowment Arm | Company | 14,388 | CHF 536.38 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 841,836 | 0.0935% |
Individual Insiders | 1,192,629 | 0.132% |
General Public | 59,944,824 | 6.66% |
Institutions | 838,452,755 | 93.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
102,410,215 | CHF 70.2b | 100% | 45.08% | |||
96,891,978 | CHF 66.4b | -0.49% | 100.0% | |||
73,773,467 | CHF 50.6b | -0.12% | 0.82% | |||
64,341,129 | CHF 44.1b | -2.3% | 0.78% | |||
37,098,776 | CHF 25.4b | -3.95% | 1.33% | |||
33,852,215 | CHF 23.2b | -0.07% | 0.94% | |||
30,554,201 | CHF 20.9b | -1.78% | 1.36% | |||
21,706,138 | CHF 14.9b | 0.3% | 1.43% | |||
17,690,508 | CHF 12.1b | -9.83% | 9.71% | |||
17,090,971 | CHF 11.7b | 0.5% | 0.91% | |||
13,130,692 | CHF 9.0b | -3.39% | 1.11% | |||
12,646,138 | CHF 8.7b | 0% | 8.54% | |||
11,004,852 | CHF 7.5b | 0% | 0.67% | |||
10,613,796 | CHF 7.3b | -1.53% | 1.26% | |||
9,711,423 | CHF 6.7b | 8.87% | 0.72% | |||
8,329,069 | CHF 5.7b | 9% | 0.73% | |||
8,243,882 | CHF 5.7b | -5.37% | 0.95% | |||
6,986,788 | CHF 4.8b | -1.81% | 0.95% | |||
6,947,395 | CHF 4.8b | -3.95% | 2.95% | |||
5,858,720 | CHF 4.0b | -9.49% | 0.82% | |||
5,774,446 | CHF 4.0b | 0.06% | 1.0% | |||
5,058,101 | CHF 3.5b | 3.46% | 1.55% | |||
5,057,736 | CHF 3.5b | 3.84% | 1.15% | |||
4,937,134 | CHF 3.4b | -1.4% | 0.9% | |||
4,835,446 | CHF 3.3b | 0.21% | 0.6% |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 21:25 |
End of Day Share Price | 2024/10/11 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eli Lilly and Company is covered by 63 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Toung | Argus Research Company |
Ishan Majumdar | Baptista Research |
Alistair Campbell | Berenberg |